{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:01:26Z","timestamp":1793235686910,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ijpharm.2016.03.030","type":"journal-article","created":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T14:00:58Z","timestamp":1458396058000},"page":"147-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment"],"prefix":"10.1016","volume":"505","author":[{"given":"Mohd.","family":"Kamran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Ahad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd.","family":"Aqil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Sarim","family":"Imam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asgar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.03.030_bib0005","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1517\/13543770902989983","article-title":"Chemical penetration enhancers: a patent review","volume":"19","author":"Ahad","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/156720111794479907","article-title":"Interactions between novel terpenes and main components of rat and human skin: mechanistic view for transdermal delivery of propranolol hydrochloride","volume":"8","author":"Ahad","year":"2011","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0015","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3109\/03639045.2010.532219","article-title":"Role of novel terpenes in transcutaneous permeation of valsartan: effectiveness and mechanism of action","volume":"37","author":"Ahad","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nano.2011.06.004","article-title":"Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan","volume":"8","author":"Ahad","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0025","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1517\/17425247.2013.783562","article-title":"Transdermal delivery of calcium channel blockers for hypertension","volume":"10","author":"Ahad","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2013.01.011","article-title":"Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment","volume":"443","author":"Ahad","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0035","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1517\/17425247.2014.914027","article-title":"Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetic in wistar albino rats","volume":"11","author":"Ahad","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijbiomac.2014.03.011","article-title":"Enhanced anti-inflammatory activity of carbopol loaded meloxicam nanoethosomes gel","volume":"67","author":"Ahad","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.ijpharm.2016.03.030_bib0045","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.drudis.2015.06.002","article-title":"Transdermal delivery of antidiabetic drugs: formulation and delivery strategies","volume":"20","author":"Ahad","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0050","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jsps.2013.12.019","article-title":"Systemic delivery of beta-blockers via transdermal route for hypertension","volume":"23","author":"Ahad","year":"2015","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0055","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3109\/10717544.2014.942444","article-title":"Transdermal delivery of angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACEIs) and others for management of hypertension","volume":"23","author":"Ahad","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0060","first-page":"1125","article-title":"Preparation, characterization and stability study of dutasteride loaded nanoemulsion for treatment of benign prostatic hypertrophy","volume":"13","author":"Ali","year":"2014","journal-title":"Iran J. Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0065","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ejpb.2004.09.006","article-title":"Proniosomes as a drug carrier for transdermal delivery of ketorolac","volume":"59","author":"Alsarra","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0070","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/10837450802309646","article-title":"Mechanism of in vitro percutaneous absorption enhancement of carvedilol by penetration enhancers","volume":"13","author":"Amin","year":"2008","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0075","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/HJH.0000000000000146","article-title":"Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension","volume":"32","author":"Anchala","year":"2014","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0080","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.drudis.2007.09.001","article-title":"Status of terpenes as skin penetration enhancers","volume":"12","author":"Aqil","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0085","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.molliq.2015.12.077","article-title":"Development of clove oil based nanoemulsion of olmesartan for transdermal delivery: box-Behnken design optimization and pharmacokinetic evaluation","volume":"214","author":"Aqil","year":"2016","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0928-0987(98)00010-4","article-title":"Influence of propylene glycol and isopropyl myristate on the in vitro percutaneous penetration of diclofenac sodium from carbopol gels","volume":"7","author":"Arellano","year":"1999","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0095","first-page":"468456","article-title":"Nanoemulsion based hydrogel for enhanced transdermal delivery of ketoprofen","author":"Arora","year":"2014","journal-title":"Adv. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0100","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1208\/s12249-009-9306-2","article-title":"Nanocarrier for the transdermal delivery of an antiparkinsonian drug","volume":"10","author":"Azeem","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijpharm.2008.08.021","article-title":"Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation","volume":"365","author":"Bachhav","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"Suppl. 2","key":"10.1016\/j.ijpharm.2016.03.030_bib0110","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/sj.jhh.1001391","article-title":"The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview","volume":"16","author":"Brunner","year":"2002","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0005-2736(02)00401-7","article-title":"Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements","volume":"1564","author":"Cevc","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00003088-200342050-00004","article-title":"Transdermal drug delivery of insulin with ultradeformable carriers","volume":"42","author":"Cevc","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0125","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jps.22292","article-title":"Optimization and formulation design of gels of Diclofenac and Curcumin for transdermal drug delivery by Box-Behnken statistical design","volume":"100","author":"Chaudhary","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.rinphs.2011.10.002","article-title":"Nanosized ethosomes bearing ketoprofen for improved transdermal delivery","volume":"1","author":"Chourasia","year":"2011","journal-title":"Results Pharm. Sci"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0140","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0142-9612(00)00063-6","article-title":"Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes","volume":"21","author":"Dayan","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/2230-973X.133053","article-title":"Enhanced transdermal permeability of piroxicam through novel nanoemulgel formulation","volume":"4","author":"Dhawan","year":"2014","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0150","article-title":"Percutaneous penetration enhancers chemical methods in penetration enhancement","author":"Dragicevic","year":"2016","journal-title":"Nanocarriers"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jphotobiol.2008.01.009","article-title":"Topical application of temoporfin-loaded invasomes for photodynamic therapy of subcutaneously implanted tumours in mice: a pilot study","volume":"91","author":"Dragicevic-Curic","year":"2008","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jconrel.2007.12.013","article-title":"Temoporfin-loaded invasomes: development, characterization and in vitro skin penetration studies","volume":"127","author":"Dragicevic-Curic","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0165","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.colsurfb.2008.12.030","article-title":"Development of different temoporfin-loaded invasomes-novel nanocarriers of temoporfin: characterization, stability and in vitro skin penetration studies","volume":"70","author":"Dragicevic-Curic","year":"2009","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0170","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.colsurfb.2009.07.005","article-title":"Development of liposomes containing ethanol for skin delivery of temoporfin: characterization and in vitro penetration studies","volume":"74","author":"Dragicevic-Curic","year":"2009","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijpharm.2011.04.020","article-title":"Assessment of fluidity of different invasomes by electron spin resonance and differential scanning calorimetry","volume":"412","author":"Dragicevic-Curic","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0180","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jconrel.2007.08.005","article-title":"Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes","volume":"123","author":"Dubey","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0185","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/0019-5154.135489","article-title":"Delivery of amphotericin B for effective treatment of candida albicans induced dermal mycosis in rats via emulgel system: formulation and evaluation","volume":"59","author":"Ganeshpurkar","year":"2014","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0190","doi-asserted-by":"crossref","first-page":"616810","DOI":"10.1155\/2013\/616810","article-title":"Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes","volume":"2013","author":"Ghanbarzadeh","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0195","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.4155\/tde.12.87","article-title":"Systemic delivery of antihypertensive drugs via skin","volume":"3","author":"Gungor","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0200","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejpb.2012.07.002","article-title":"Development and characterization of colloidal soft nano-carriers for transdermal delivery and bioavailability enhancement of an angiotensin II receptor blocker","volume":"82","author":"Hathout","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0205","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jps.2600521210","article-title":"Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices","volume":"52","author":"Higuchi","year":"1963","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0210","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1023\/A:1018963910260","article-title":"Estradiol permeation from nonionic surfactant vesicles through human stratum corneum in vitro","volume":"11","author":"Hofland","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0215","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0304-4165(02)00415-4","article-title":"The in vivo and in vitro interactions of elastic and rigid vesicles with human skin","volume":"1573","author":"Honeywell-Nguyen","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0220","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3109\/10717544.2013.870260","article-title":"Formulation by design-based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study","volume":"22","author":"Imam","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0225","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)70151-3","article-title":"Global burden of hypertension: analysis of worldwide data","volume":"365","author":"Kearney","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0230","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0005-2760(96)00126-9","article-title":"Interaction of liposomes with human skin in vitro\u2013the influence of lipid composition and structure","volume":"1304","author":"Kirjavainen","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0235","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0168-3659(98)00152-7","article-title":"Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers","volume":"58","author":"Kirjavainen","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0240","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0928-0987(98)00037-2","article-title":"Liposome-skin interactions and their effects on the skin permeation of drugs","volume":"7","author":"Kirjavainen","year":"1999","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0245","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0378-5173(83)90064-9","article-title":"Mechanism of solute release from porous hydrophilic polymers","volume":"15","author":"Korsmeyer","year":"1983","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0250","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/00004872-200106001-00004","article-title":"The pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interaction","author":"Laeis","year":"2001","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0255","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1208\/s12249-013-0034-2","article-title":"Enhanced topical delivery of finasteride using glyceryl monooleate-based liquid crystalline nanoparticles stabilized by cremophor surfactants","volume":"15","author":"Madheswaran","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0260","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.2147\/IJN.S46748","article-title":"Enhanced transdermal bioavailability of testosterone propionate via surfactant-modified ethosomes","volume":"8","author":"Meng","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0265","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2174\/1567201811310050002","article-title":"Formulation and optimization of ethosomes for transdermal delivery of ropinirole hydrochloride","volume":"10","author":"Mishra","year":"2013","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0270","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijpharm.2009.06.040","article-title":"Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil","volume":"380","author":"Mura","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0275","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1161\/HYPERTENSIONAHA.107.105205","article-title":"Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension","volume":"51","author":"Ong","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0280","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/2229-4708.81092","article-title":"Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies","volume":"2","author":"Patel","year":"2011","journal-title":"Pharm. Methods"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0285","doi-asserted-by":"crossref","first-page":"341218","DOI":"10.1155\/2013\/341218","article-title":"Hp-beta-CD-voriconazole in situ gelling system for ocular drug delivery: in vitro, stability, and antifungal activities assessment","volume":"2013","author":"Pawar","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0290","first-page":"110","article-title":"Analysis of Fickian and non-Fickian drug release from polymers","volume":"60","author":"Peppas","year":"1985","journal-title":"Pharm. Acta Helv."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0295","first-page":"1","article-title":"Invasomes of isradipine for enhanced transdermal delivery against hypertension: formulation, characterization, and in vivo pharmacodynamic study","author":"Qadri","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0300","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4103\/0975-7406.103274","article-title":"Formulation and optimization of nano-sized ethosomes for enhanced transdermal delivery of cromolyn sodium","volume":"4","author":"Rakesh","year":"2012","journal-title":"J. Pharm. Bioall. Sci."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0305","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2165\/00003495-200868090-00005","article-title":"Olmesartan medoxomil: a review of its use in the management of hypertension","volume":"68","author":"Scott","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0310","first-page":"1","article-title":"Transdermal drug delivery systems for antihypertensive drugs\u2014a review","volume":"1","author":"Selvam","year":"2010","journal-title":"Int. J. Pharm. Biomed. Res."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0315","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4103\/0975-1483.96622","article-title":"Simultaneous quantitative analysis of olmesartan medoxomil and amlodipine besylate in plasma by high-performance liquid chromatography technique","volume":"4","author":"Shah","year":"2012","journal-title":"J. Young Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0320","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijpharm.2015.05.042","article-title":"LeciPlex, invasomes, and liposomes: a skin penetration study","volume":"490","author":"Shah","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0325","doi-asserted-by":"crossref","first-page":"E104","DOI":"10.1208\/pt0804104","article-title":"Nanoemulsions as vehicles for transdermal delivery of aceclofenac","volume":"8","author":"Shakeel","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0330","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1208\/s12249-012-9767-6","article-title":"Ligustrazine phosphate ethosomes for treatment of Alzheimer's disease, in vitro and in animal model studies","volume":"13","author":"Shi","year":"2012","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0335","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0168-3659(99)00222-9","article-title":"Ethosomes \u2212 novel vesicular carriers for enhanced delivery: characterization and skin penetration properties","volume":"65","author":"Touitou","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0340","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejpb.2013.11.004","article-title":"Influence of massage and occlusion on the ex vivo skin penetration of rigid liposomes and invasomes","volume":"86","author":"Trauer","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0345","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2003.11.020","article-title":"Influence of carrageenan on the rheology and skin permeation of microemulsion formulations","volume":"95","author":"Valenta","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0350","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/2230-973X.138342","article-title":"Nanovesicles for transdermal delivery of felodipine: development, characterization, and pharmacokinetics","volume":"4","author":"Yusuf","year":"2014","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0355","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0005-2736(95)00100-H","article-title":"Interaction of phosphatidylcholine liposomes with the human stratum corneum","volume":"1237","author":"Zellmer","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2016.03.030_bib0360","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/08982100902722381","article-title":"Preparation of matrine ethosome, its percutaneous permeation in vitro and anti-inflammatory activity in vivo in rats","volume":"19","author":"Zhaowu","year":"2009","journal-title":"J. Liposome Res."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316302307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316302307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T02:26:02Z","timestamp":1536891962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316302307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":72,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0378517316302307"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.03.030","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}